KMS Medisurgi Board of Directors

Get the latest insights into the leadership at KMS Medisurgi. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Siddharth KanakiaChairman & Managing Director
Rohan Devang KanakiaNon Independent & Non Executive Director
Monali KanakiaExecutive Director
Gaurang Prataprai KanakiaNon Independent & Non Executive Director
Hardik Rajnikant BhattNon Executive Independent Director
Kamlesh Chunilal RajaniNon Executive Independent Director
Pratik Pravin TarparaNon Executive Independent Director
Pooja SoniCompany Secretary & Compliance Officer

KMS Medisurgi Share price

KMSMEDI

126.5

0.00 (0.00%)
Last updated on 23 Apr, 2026 | 15:31 IST
Today's High

00

Today's Low

00

52 Week Low

120.50

52 Week High

132.30

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

KMS Medisurgi FAQs

The board at KMS Medisurgi consists of experienced professionals, including Siddharth Kanakia, Rohan Devang Kanakia, and others, overseeing the company’s strategic and corporate governance.

Directors at KMS Medisurgi are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Siddharth Kanakia is the current chairman at KMS Medisurgi.

Executive directors at KMS Medisurgi are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, KMS Medisurgi adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At KMS Medisurgi, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost